Overview of cost-consequence modeling in outcomes research

Area of Science:

• Health economics
• Outcomes research
• Clinical trial analysis

Background:

• Clinical trials often focus on biologic effects, neglecting broader outcomes of pharmaceutical use.
• There's a growing need for comprehensive data on treatment costs, risks, and benefits.
• Outcomes research aims to provide a wider perspective on the results of clinical treatments.

Purpose of the Study:

• To define and differentiate key concepts in outcomes research, including cost-effectiveness and cost-consequence analysis.
• To highlight the importance of considering direct medical, indirect medical, and humanistic outcomes.
• To emphasize the utility of modeling techniques in therapeutic decision-making when clinical trials are insufficient.

Main Methods:

• Cost-effectiveness analysis: Compares treatment options based on monetary cost per unit of effectiveness.
• Cost-consequence analysis (or cost-outcome models): Assesses costs alongside a diverse range of clinical and humanistic outcomes.
• Utilizes modeling techniques to synthesize data for therapeutic decision-making.

Main Results:

• Effectiveness measures include years of life saved, avoided hospitalizations, and treatment successes.
• Direct medical costs encompass prevention, detection, treatment, and rehabilitation expenses.
• Indirect medical costs relate to productivity losses, while humanistic outcomes address quality of life and patient satisfaction.

Conclusions:

• Outcomes research provides essential information on the broader impact of clinical treatments.
• Modeling techniques are valuable tools for making informed therapeutic decisions.
• A comprehensive approach considering economic and humanistic factors is crucial for evaluating treatments.